Pro více informací a konzultace VOLEJTE: 603 466 620 !
nutrigenomic scientifical sources Články a odborné studie

Pennington CR, Powell-Tuck J, Shaffer J. Review article: artificial nutritional support for improved patient care. Aliment Pharmacol Ther 1995;9(5):471–81.

Grant JP. Nutritional support in critically ill patients. Ann Surg 1994;220(5):610–6.

Soeters PB, Dejong CH, von Meyenfeldt MF. Parenteral versus enteral nutrition: can we get rid of the myths? Nestle Nutr Workshop Ser Clin Perform Programme 2002;7:183–94.

Sobotka L. Nutritional support in severe malnutrition. In: Basics in Clinical Nutrition. 2nd edition (editor L.Sobotka). Praha: Galén, 2001, p. 161–164.

Garcia de Lorenzo y Mateos A, Culebras JM. Nutritional and metabolic support: converging concepts. Nutrition 1991;7(3):163–7.

Mattox TW, Bertch KE, Mirtallo JM, Strausberg KM, Cuddy PG. Recent advances: parenteral nutrition support. Ann Pharmacother 1995;29(2):174–80.

Bresson JL, Bader B, Rocchiccioli F, Mariotti A, Ricour C, Sachs C, Rey J. Protein-metabolism kinetics and energy-substrate utilization in infants fed parenteral solutions with different glucose-fat ratios. Am J Clin Nutr 1991; 54(2):370–6.

Berger V, Perier S, Pachiaudi C, Normand S, Louisot P, Martin A. Dietary specific sugars for serum protein enzymatic glycosylation in man. Metabolism 1998;47(12):1499–503.

Rambal C, Pachiaudi C, Normand S, Riou JP, Louisot P, Martin A. Effects of specific dietary sugars on the incorporation of 13C label from dietary glucose into neutral sugars of rat intestine and serum glycoproteins. Br J Nutr 1995;73(3):443–54.

Barret JP, Jeschke MG, Herndon DN. Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications. J Trauma 2001;51(4):736–9.

Sobotka L, Soeters PB. Nutritional support in critically ill patients. In: Basics in Clinical Nutrition. 2nd edition (editor L. Sobotka). Praha: Galén, 2001, p. 166.

Linseisen J, Wolfram G. Efficacy of different triglycerides in total parenteral nutrition for preventing atrophy of the gut in traumatized rats. JPEN J Parenter Enteral Nutr 1997;21(1):21–6.

Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz J Med Biol Res 2003;36(4):433–46.

Jorquera F, Culebras JM, Gonzalez-Gallego J. Influence of nutrition on liver oxidative metabolism. Nutrition 1996;12(6):442–7.

Hawker FH. How to feed patients with sepsis. Curr Opin Crit Care 2000;6(4):247–252.

RG. Nutrition support in critical illness. Nutr Clin Pract 1994;9(4):127–39.

Bower RH. Nutrition during critical illness and sepsis. New Horiz 1993;1(2):348–52.

Cochran EB, Kamper CA, Phelps SJ, Brown RO. Parenteral nutrition in the critically ill patient. Clin Pharm 1989;8(11):783–99.

Carpentier YA, Dupont IE. Optimizing intravenous supply of functional lipid components. Nestle Nutr Workshop Ser Clin Perform Programme 2002;7:87–98.

Chanda S, Mehendale HM, Chandra S. Nutritional modulation of the final outcome of hepatotoxic injury by energy substrates: an hypothesis for the mechanism. Med Hypotheses 1996;46(3):261–8.

Mingrone G, De Gaetano A, Greco AV, Capristo E, Castagneto M, Gasbarrini G. Medium-chain triglycerides for parenteral nutrition: kinetic profile in humans. Nutrition 1995;11(5):418–22.

Ulrich H, Pastores SM, Katz DP, Kvetan V. Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition 1996;12(4):231–8.

Faucher M, Bregeon F, Gainnier M, Thirion X, Auffray JP, Papazian L. Cardiopulmonary effects of lipid emulsions in patients with ARDS. Chest 2003;124(1):285–91.

Furst P. New parenteral substrates in clinical nutrition. Part II. New substrates in lipid nutrition. Eur J Clin Nutr 1994;48(10):681–91.

Beaufrere B, Chassard D, Broussolle C, Riou JP, Beylot M. Effects of D-beta-hydroxybutyrate and long- and medium-chain triglycerides on leucine metabolism in humans. Am J Physiol 1992;262(3 Pt 1):E268–74.

Martin-Pena G, Culebras JM, De P, Barro-Ordovas JP, Catala-Pizarro R, Ruiz-Galiana J. Effects of 2 lipid emulsions (LCT versus MCT/LCT) on the fatty acid composition of plasma phospholipid: a double-blind randomized trial. JPEN J Parenter Enteral Nutr 2002;26(1):30–41.

Planas M, Masclans JR, Iglesia R, Porta I, Valls M, Bermejo B. Eicosanoids and fat emulsions in acute respiratory distress syndrome patients. Nutrition 1997;13(3):202–5.

Smyrniotis VE, Kostopanagiotou GG, Arkadopoulos NF, Theodoraki KA, Kotsis,TE, Lambrou AT, Vassiliou JG. Long-chain versus medium-chain lipids in acute pancreatitis complicated by acute respiratory distress syndrome: effects on pulmonary hemodynamics and gas exchange. Clin Nutr 2001; 20(2):139–43.

Cynober L. Role of new nitrogen substrates during peri-operative artificial nutrition in adults Ann Fr Anesth Reanim 1995;14 Suppl 2:102–6.

Furst P. New developments in glutamine delivery. J Nutr 2001;131(9 Suppl):2562S–8S.

Furst P. Old and new substrates in clinical nutrition. J Nutr 1998;128(5):789–96.

Paxton J, Williamson J. Nutrient substrates. Making choices in the 1990s. J Burn Care Rehabil 1991;12(2):198–202.

Lourenco R, Camilo ME. Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp 2002;17(6):262–70.

Sobotka L, Allison SP, Stanga, Z. Water and Electrolytes. In: Basics in Clinical Nutrition. 2nd edition (editor L. Sobotka). Praha: Galén, 2001, p. 51–62.

Pertkiewicz M, Szczygiel B, Sobotka L. Composition of nutritional admixtures and formulas for parenteral nutrition. In: Basics in Clinical Nutrition. 2nd edition (editor L. Sobotka). Praha: Galén, 2001, p. 124–129.

Craig RM, Mikalunas V, Rubin H. Vitamins and trace elements in TPN. JPEN J Parenter Enteral Nutr 2002;26(4):256.

Kelly DG. Guidelines and available products for parenteral vitamins and trace elements. JPEN J Parenter Enteral Nutr 2002;26(5 Suppl):S34–6.

Reimund JM, Arondel Y, Duclos B, Baumann R. Vitamins and trace elements in home parenteral nutrition patients. J Nutr Health Aging 2000;4(1):13–8. Chiolero RL, Tappy L, Berger MM. Timing of nutritional support. Nestle Nutr Workshop Ser Clin Perform Programme 2002;7:151–64.

Heys SD, Ogston KN. Peri-operative nutritional support: controversies and debates. Int J Surg Investig 2000;2(2):107–15.

Biffl WL, Moore EE, Haenel JB. Nutrition support of the trauma patient. Nutrition 2002;18(11–12):960–5.

doc.MUDr. Ondřej Šeda, PhD. Aktuální genetika

Sobotka L. Metabolic complications of parenteral nutrition. In: Basics in Clinical Nutrition. 2nd edition (editor L. Sobotka). Praha: Galén, 2001, p. 139–141.

Ordovas JM, Mooser V, Nutrigenomics and nutrigenetics, Curr Opin Lipidol, 2004 Apr;15(2):101-8.

Knihy

Berdanier, C., Gorny, J. R., Yousef, A. E. Advanced Nutrition: Macronutrients, 2nd ed. Boca Raton, FL: CRC Press, 2000.

Conrad, K. Eat Well, Feel Well.New York, NY: Clarkson Potter, 2000.

Food and Nutrition Board. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: National Academies Press, 2005.

Garrison, R., Somer, E. The Nutrition Desk Reference. New York, NY: McGraw-Hill, 1998.

Larson Duyff, R. ADA Complete Food and Nutrition Guide, 3rd ed. Chicago, IL: American Dietetic Association, 2006.

Newstrom, H. Nutrients Catalog: Vitamins, Minerals, Amino Acids, Macronutrients-Beneficials Use, Helpers, Inhibitors, Food Sources, Intake Recommendations. Jefferson, NC: McFarland & Company, 1993.

Organizace

American Dietetic Association (ADA). 120 South Riverside Plaza, Suite 2000, Chicago, IL 60606-6995. 1-800/877-1600. http://www.eatright.org.

American Society for Nutrition (ASN). 9650 Rockville Pike, Bethesda, MD 20814. (301) 634-7050. http://www.nutrition.org.

U.S. Department of Agriculture, Food and Nutrition Information Center. National Agricultural Library,10301 Baltimore Avenue, Room 105, Beltsville, MD 20705. (301) 504-5414. http://www.nal.usda.gov.

USDA Center for Nutrition Policy and Promotion (CNPP). 3101 Park Center Drive, 10th Floor, Alexandria, VA 22302-1594. (703) 305-7600. http://www.cnpp.usda.org.

Zdroje citací v závěrečné zprávě

Abu-Amero, K. K., Al-Boudari, O. M., Mohamed, G. H., & Dzimiri, N. (2006). The Glu27 genotypes of the beta2-adrenergic receptor are predictors for severe coronary artery disease. BMC Med Genet, 7, 31.

Adamo, K. B., Sigal, R. J., Williams, K., Kenny, G., Prud'homme, D., & Tesson, F. (2005). Influence of Pro12Ala peroxisome proliferator-activated receptor gamma2 polymorphism on glucose response to exercise training in type 2 diabetes. Diabetologia, 48(8), 1503-1509.

Albala, B. C., Jimenez, R. B., Perez, B. F., & Liberman, G. C. (2006). [Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance]. Rev Med Chil, 134(3), 372-379.

Albala, C., Santos, J. L., Cifuentes, M., Villarroel, A. C., Lera, L., Liberman, C., et al. (2004). Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes Res, 12(2), 340-345.

Allison, D. B., Heo, M., Faith, M. S., & Pietrobelli, A. (1998). Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with body mass index. Int J Obes Relat Metab Disord, 22(6), 559-566.

Baier, L. J., Sacchettini, J. C., Knowler, W. C., Eads, J., Paolisso, G., Tataranni, P. A., et al. (1995). An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest, 95(3), 1281-1287.

Corbalan, M. S., Marti, A., Forga, L., Martinez-Gonzalez, M. A., & Martinez, J. A. (2002). The 27Glu polymorphism of the beta2-adrenergic receptor gene interacts with physical activity influencing obesity risk among female subjects. Clin Genet, 61(4), 305-307.

de Luis, D. A., Aller, R., Izaola, O., Sagrado, M. G., & Conde, R. (2006). Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects. Ann Nutr Metab, 50(4), 354-360.

Dedoussis, G. V., Manios, Y., Kourlaba, G., Kanoni, S., Lagou, V., Butler, J., et al. (2010). An age-dependent diet-modified effect of the PPARgamma Pro12Ala polymorphism in children. Metabolism.

Ellsworth, D. L., Coady, S. A., Chen, W., Srinivasan, S. R., Boerwinkle, E., & Berenson, G. S. (2005). Interactive effects between polymorphisms in the beta-adrenergic receptors and longitudinal changes in obesity. Obes Res, 13(3), 519-526.

Fujisawa, T., Ikegami, H., Kawaguchi, Y., & Ogihara, T. (1998). Meta-analysis of the association of Trp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab, 83(7), 2441-2444.

Gowdak, M. M., Laterza, M. C., Rondon, M. U., Trombetta, I. C., Pereira, A. C., Krieger, J. E., et al. (2010). A high-fat meal impairs muscle vasodilatation response to mental stress in humans with Glu27 beta2-adrenoceptor polymorphism. Lipids Health Dis, 9, 55.

Gowdak, M. M., Laterza, M. C., Rondon, M. U., Trombetta, I. C., Pereira, A. C., Krieger, J. E., et al. (2010). A high-fat meal impairs muscle vasodilatation response to mental stress in humans with Glu27 beta2-adrenoceptor polymorphism. Lipids Health Dis, 9, 55.

Hegele, R. A., Harris, S. B., Hanley, A. J., Sadikian, S., Connelly, P. W., & Zinman, B. (1996). Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab, 81(12), 4334-4337.

Hoffstedt, J., Poirier, O., Thorne, A., Lonnqvist, F., Herrmann, S. M., Cambien, F., et al. (1999). Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes, 48(1), 203-205.

Chamberlain, A. M., Schreiner, P. J., Fornage, M., Loria, C. M., Siscovick, D., & Boerwinkle, E. (2009). Ala54Thr polymorphism of the fatty acid binding protein 2 gene and saturated fat intake in relation to lipid levels and insulin resistance: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Metabolism, 58(9), 1222-1228.

Kahara, T., Takamura, T., Hayakawa, T., Nagai, Y., Yamaguchi, H., Katsuki, T., et al. (2003). PPARgamma gene polymorphism is associated with exercise-mediated changes of insulin resistance in healthy men. Metabolism, 52(2), 209-212.

Kim, O. Y., Cho, E. Y., Park, H. Y., Jang, Y., & Lee, J. H. (2004). Additive effect of the mutations in the beta3-adrenoceptor gene and UCP3 gene promoter on body fat distribution and glycemic control after weight reduction in overweight subjects with CAD or metabolic syndrome. Int J Obes Relat Metab Disord, 28(3), 434-441.

Koika, V., Marioli, D. J., Saltamavros, A. D., Vervita, V., Koufogiannis, K. D., Adonakis, G., et al. (2009). Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome. Eur J Endocrinol, 161(2), 317-322.

Kulminski, A. M., Culminskaya, I., Ukraintseva, S. V., Arbeev, K. G., Land, K. C., & Yashin, A. I. (2010). Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context. Mech Ageing Dev, 131(5), 338-345.

Kulminski, A. M., Culminskaya, I., Ukraintseva, S. V., Arbeev, K. G., Land, K. C., & Yashin, A. I. (2010). Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context. Mech Ageing Dev, 131(5), 338-345.

Kunnas, T., Lahtio, R., Kortelainen, M. L., Kalela, A., & Nikkari, S. T. (2009). Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women. Lipids Health Dis, 8, 43.

Kunnas, T., Lahtio, R., Kortelainen, M. L., Kalela, A., & Nikkari, S. T. (2009). Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women. Lipids Health Dis, 8, 43.

Lefevre, M., Lovejoy, J. C., Smith, S. R., Delany, J. P., Champagne, C., Most, M. M., et al. (2005). Comparison of the acute response to meals enriched with cis- or trans-fatty acids on glucose and lipids in overweight individuals with differing FABP2 genotypes. Metabolism, 54(12), 1652-1658.

Levy, E., Menard, D., Delvin, E., Stan, S., Mitchell, G., Lambert, M., et al. (2001). The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem, 276(43), 39679-39684.

Lindi, V., Schwab, U., Louheranta, A., Laakso, M., Vessby, B., Hermansen, K., et al. (2003). Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Mol Genet Metab, 79(1), 52-60.

Luan, J., Browne, P. O., Harding, A. H., Halsall, D. J., O'Rahilly, S., Chatterjee, V. K., et al. (2001). Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes, 50(3), 686-689.

Marin, C., Perez-Jimenez, F., Gomez, P., Delgado, J., Paniagua, J. A., Lozano, A., et al. (2005). The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am J Clin Nutr, 82(1), 196-200.

Marti, A., Corbalan, M. S., Martinez-Gonzalez, M. A., & Martinez, J. A. (2002). TRP64ARG polymorphism of the beta 3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle. Diabetes Obes Metab, 4(6), 428-430.

Marti, A., Corbalan, M. S., Martinez-Gonzalez, M. A., Forga, L., & Martinez, J. A. (2002). CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPARgamma gene. J Physiol Biochem, 58(4), 219-220.

Marti, A., Martinez-Gonzalez, M. A., & Martinez, J. A. (2008). Interaction between genes and lifestyle factors on obesity. Proc Nutr Soc, 67(1), 1-8.

Martinez, J. A., Corbalan, M. S., Sanchez-Villegas, A., Forga, L., Marti, A., & Martinez-Gonzalez, M. A. (2003). Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism. J Nutr, 133(8), 2549-2554.

Masugi, J., Tamori, Y., Mori, H., Koike, T., & Kasuga, M. (2000). Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun, 268(1), 178-182.

Memisoglu, A., Hu, F. B., Hankinson, S. E., Manson, J. E., De Vivo, I., Willett, W. C., et al. (2003). Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet, 12(22), 2923-2929.

Miyaki, K., Sutani, S., Kikuchi, H., Takei, I., Murata, M., Watanabe, K., et al. (2005). Increased risk of obesity resulting from the interaction between high energy intake and the Trp64Arg polymorphism of the beta3-adrenergic receptor gene in healthy Japanese men. J Epidemiol, 15(6), 203-210.

Miyaki, K., Sutani, S., Kikuchi, H., Takei, I., Murata, M., Watanabe, K., et al. (2005). Increased risk of obesity resulting from the interaction between high energy intake and the Trp64Arg polymorphism of the beta3-adrenergic receptor gene in healthy Japanese men. J Epidemiol, 15(6), 203-210.

Morcillo, S., Rojo-Martinez, G., Cardona, F., Almaraz Mde, L., de Adana Mde, L., Esteva, I., et al. (2007). Effect of the interaction between the fatty acid binding protein 2 gene Ala54Thr polymorphism and dietary fatty acids on peripheral insulin sensitivity: a cross-sectional study. Am J Clin Nutr, 86(4), 1232-1237.

Morita, E., Taniguchi, H., & Sakaue, M. (2009). Trp64Arg polymorphism in beta3-adrenergic receptor gene is associated with decreased fat oxidation both in resting and aerobic exercise in the Japanese male. Exp Diabetes Res, 2009, 605139.

Nakamura, M., Tanaka, M., Abe, S., Itoh, K., Imai, K., Masuda, T., et al. (2000). Association between beta 3-adrenergic receptor polymorphism and a lower reduction in the ratio of visceral fat to subcutaneous fat area during weight loss in Japanese obese women. Nutrition Research, 20(1), 25-34.

Nakamura, M., Tanaka, M., Abe, S., Itoh, K., Imai, K., Masuda, T., et al. (2000). Association between beta 3-adrenergic receptor polymorphism and a lower reduction in the ratio of visceral fat to subcutaneous fat area during weight loss in Japanese obese women. Nutrition Research, 20(1), 25-34.

Nelson, T. L., Fingerlin, T. E., Moss, L., Barmada, M. M., Ferrell, R. E., & Norris, J. M. (2007). The PPARgamma Pro12Ala polymorphism is not associated with body mass index or waist circumference among Hispanics from Colorado. Ann Nutr Metab, 51(3), 252-257.

Oomen, J. M., Waijers, P. M., van Rossum, C., Hoebee, B., Saris, W. H., & van Baak, M. A. (2005). Influence of beta(2)-adrenoceptor gene polymorphisms on diet-induced thermogenesis. Br J Nutr, 94(5), 647-654.

Orio, F., Jr., Matarese, G., Di Biase, S., Palomba, S., Labella, D., Sanna, V., et al. (2003). Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome. J Clin Endocrinol Metab, 88(12), 5887-5892.

Osawa, H., Tabara, Y., Kawamoto, R., Ohashi, J., Ochi, M., Onuma, H., et al. (2009). PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population. Clin Endocrinol (Oxf), 71(3), 341-345.

Phares, D. A., Halverstadt, A. A., Shuldiner, A. R., Ferrell, R. E., Douglass, L. W., Ryan, A. S., et al. (2004). Association between body fat response to exercise training and multilocus ADR genotypes. Obes Res, 12(5), 807-815.

Phares, D. A., Halverstadt, A. A., Shuldiner, A. R., Ferrell, R. E., Douglass, L. W., Ryan, A. S., et al. (2004). Association between body fat response to exercise training and multilocus ADR genotypes. Obes Res, 12(5), 807-815.

Pojoga, L., Kolatkar, N. S., Williams, J. S., Perlstein, T. S., Jeunemaitre, X., Brown, N. J., et al. (2006). Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension, 48(5), 892-900.

Pratley, R. E., Baier, L., Pan, D. A., Salbe, A. D., Storlien, L., Ravussin, E., et al. (2000). Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res, 41(12), 2002-2008.

Razquin, C., Alfredo Martinez, J., Martinez-Gonzalez, M. A., Corella, D., Santos, J. M., & Marti, A. (2009). The Mediterranean diet protects against waist circumference enlargement in 12Ala carriers for the PPARgamma gene: 2 years' follow-up of 774 subjects at high cardiovascular risk. Br J Nutr, 102(5), 672-679.

Rosado, E. L., Bressan, J., Martins, M. F., Cecon, P. R., & Martinez, J. A. (2007). Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women. Appetite, 49(3), 635-643.

Ruiz, J. R., Larrarte, E., Margareto, J., Ares, R., & Labayen, I. (2010). Role of beta(2)-Adrenergic Receptor Polymorphisms on Body Weight and Body Composition Response to Energy Restriction in Obese Women: Preliminary Results. Obesity (Silver Spring).

Selva, D. M., & Hammond, G. L. (2009). Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression. Endocrinology, 150(5), 2183-2189.

Shiwaku, K., Nogi, A., Anuurad, E., Kitajima, K., Enkhmaa, B., Shimono, K., et al. (2003). Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Int J Obes Relat Metab Disord, 27(9), 1028-1036.

Takakura, Y., Yoshioka, K., Umekawa, T., Kogure, A., Toda, H., Yoshikawa, T., et al. (2005). Thr54 allele of the FABP2 gene affects resting metabolic rate and visceral obesity. Diabetes Res Clin Pract, 67(1), 36-42.

Ukkola, O., Tremblay, A., & Bouchard, C. (2001). Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding. Int J Obes Relat Metab Disord, 25(11), 1604-1608.

Umekawa, T., Yoshida, T., Sakane, N., Kogure, A., Kondo, M., & Honjyo, H. (1999). Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes, 48(1), 117-120.

Verier, C., Meirhaeghe, A., Bokor, S., Breidenassel, C., Manios, Y., Molnar, D., et al. (2010). Breast-feeding modulates the influence of the peroxisome proliferator-activated receptor-gamma (PPARG2) Pro12Ala polymorphism on adiposity in adolescents: The Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) cross-sectional study. Diabetes Care, 33(1), 190-196.

Ylonen, S. K., Salminen, I., Lyssenko, V., Virtanen, S. M., Groop, L., Aro, A., et al. (2008). The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism. Eur J Clin Nutr, 62(12), 1432-1439.